封面
市场调查报告书
商品编码
1517626

骨科影像设备市场规模 - 按产品类型(X 光、CT、MRI、超音波、EOS 影像系统)、适应症(创伤病例、运动伤害、脊椎损伤、关节炎、骨骼疾病、肌肉萎缩)、最终用途和预测, 2024 - 2032

Orthopedic Imaging Equipment Market Size - By Product Type (X-Ray, CT, MRI, Ultrasound, EOS Imaging System), Indication (Trauma Cases, Sport Injuries, Spinal Injuries, Arthritis, Bone Disorders, Muscle Atrophy), End-use & Forecast, 2024 - 2032

出版日期: | 出版商: Global Market Insights Inc. | 英文 115 Pages | 商品交期: 2-3个工作天内

价格
简介目录

在人工智慧不断融入以提高诊断准确性和效率的推动下,骨科成像设备市场规模从 2024 年到 2032 年的复合年增长率预计将达到 4.8%。该公司正在推出新的人工智慧整合设备,以改善影像分析和解释,简化工作流程,减少人为错误并提供个人化的治疗计划。

此外,人工智慧在辅助即时诊断和决策方面发挥着更重要的作用。骨科影像领域的持续发展使其更加精确、可靠且易于使用,这将有利于产品需求。例如,2022 年3 月,Pixee Medical 宣布在美国推出Knee+ AR,这是其首款用于全膝关节置换术的增强现实引导系统,同时透过创新的电脑辅助解决方案改进骨科成像设备,以提高手术精度。

该行业分为产品类型、适应症、最终用途和地区。

由于先进设备的更高整合度以改善患者护理,诊断影像中心最终用途领域的骨科影像设备市场份额将在 2024 年至 2032 年间实现可观的成长率。这些中心采用最先进的技术,例如 MRI、CT 扫描和超音波来进行详细的肌肉骨骼评估。他们也利用人工智慧驱动的工具来增强成像能力,以实现更精确、更快速的诊断。

就产品类型而言,预计超音波领域的骨科成像设备市场从2024年至2032年将出现显着的复合年增长率。超音波技术越来越多地应用于骨科成像设备,以提供肌肉、肌腱和关节的即时动态影像。快速进步也增强了他们的诊断能力,以实现更准确和高效的评估。医疗保健提供者正在进一步将超音波解决方案纳入其实践中,透过非侵入性和无辐射成像来改善患者的治疗结果。

在人口老化和对微创手术日益偏好的推动下,到 2032 年,亚太地区骨科影像设备产业规模将创下显着的复合年增长率。亚太地区的医疗保健提供者正在扩大先进影像技术的使用,以满足提高诊断精度和患者治疗效果的需求。随着需求的不断增长,影像设备的不断进步将支持采用微创技术来重塑骨科景观,以确保该地区提供更好、更有效率的照护。

目录

第 1 章:方法与范围

第 2 章:执行摘要

第 3 章:产业洞察

  • 产业生态系统分析
  • 产业影响力
    • 成长动力
      • 骨科疾病的发生率上升
      • 骨科成像领域的技术进步
      • 对早期疾病诊断的认识不断提高
      • 微创手术的需求不断增加
    • 产业陷阱与挑战
      • 辐射暴露造成不良影响的风险
      • 设备成本高
  • 成长潜力分析
  • 技术景观
  • 监管环境
  • 波特的分析
  • PESTEL分析

第 4 章:竞争格局

  • 介绍
  • 公司市占率分析
  • 竞争定位矩阵
  • 战略展望矩阵

第 5 章:市场估计与预测:按产品类型,2021 - 2032 年

  • 主要趋势
  • X射线系统
  • CT扫描仪
  • 核磁共振系统
  • EOS影像系统
  • 超音波
  • 核子造影系统

第 6 章:市场估计与预测:按指标划分,2021 - 2032 年

  • 主要趋势
  • 外伤病例
  • 运动伤害
  • 脊椎损伤
  • 关节炎
  • 骨骼疾病
  • 肌肉骨骼癌
  • 肌肉萎缩
  • 其他适应症

第 7 章:市场估计与预测:按最终用途,2021 - 2032 年

  • 主要趋势
  • 医院
  • 诊断影像中心
  • 其他最终用户

第 8 章:市场估计与预测:按地区,2021 - 2032

  • 主要趋势
  • 北美洲
    • 我们
    • 加拿大
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 西班牙
    • 义大利
    • 荷兰
    • 欧洲其他地区
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 韩国
    • 亚太地区其他地区
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
    • 拉丁美洲其他地区
  • 中东和非洲
    • 沙乌地阿拉伯
    • 南非
    • 阿联酋
    • 中东和非洲其他地区

第 9 章:公司简介

  • Canon Inc.
  • Carestream Health
  • EOS imaging
  • Esaote SPA
  • FUJIFILM Holdings Corporation
  • GE HealthCare Technologies Inc.
  • Hologic, Inc.
  • Koninklijke Philips NV
  • Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
  • Shimadzu Corporation
  • Siemens Healthineers AG
简介目录
Product Code: 9157

Orthopedic Imaging Equipment Market size is set to record 4.8% CAGR from 2024 to 2032, driven by increasing incorporation of AI to enhance diagnostic accuracy and efficiency. Companies are launching new AI-integrated devices for improving image analysis and interpretation for streamlining workflows for reducing human error and providing personalized treatment plans.

In addition, AI is playing an even more significant role to assist in real-time diagnosis and decision-making. Such ongoing developments for transforming the orthopedic imaging field to make it more precise, reliable, and accessible will favor the product demand. For instance, in March 2022, Pixee Medical announced the U.S. launch of Knee+ AR, its first augmented reality guidance system for total knee arthroplasty while advancing orthopedic imaging equipment with innovative computer-assisted solutions for enhanced surgical precision.

The industry is segmented into product type, indication, end-use, and region.

Orthopedic imaging equipment market share from the diagnostic imaging centers end-use segment will record a decent growth rate between 2024 and 2032, due to higher integration of advanced devices to improve patient care. These centers are adopting state-of-the-art technologies, such as MRI, CT scans, and ultrasound for detailed musculoskeletal assessments. They are also enhancing their imaging capabilities with AI-driven tools for more precise and quicker diagnoses.

In terms of product type, the orthopedic imaging equipment market from the ultrasound segment is anticipated to witness a significant CAGR from 2024-2032. Ultrasound technology is increasingly utilized in orthopedic imaging equipment for providing real-time, dynamic images of muscles, tendons, and joints. Rapid advancements are also enhancing their diagnostic capabilities for enabling more accurate and efficient evaluations. Healthcare providers are further incorporating ultrasound solutions into their practices for improving patient outcomes with non-invasive and radiation-free imaging.

Asia Pacific orthopedic imaging equipment industry size will record notable CAGR through 2032, driven by the presence of an aging population and increasing preference for minimally invasive procedures. Healthcare providers in APAC are expanding the use of advanced imaging technologies to meet the needs for enhancing diagnostic precision and patient outcomes. As the demand is rising, the ongoing advancements in imaging equipment will support the adoption of minimally invasive techniques for reshaping the orthopedic landscape for ensuring better and more efficient care in the region.

Table of Contents

Chapter 1 Methodology & Scope

  • 1.1 Market scope & definitions
  • 1.2 Research design
    • 1.2.1 Research approach
    • 1.2.2 Data collection methods
  • 1.3 Base estimates & calculations
    • 1.3.1 Base year calculation
    • 1.3.2 Key trends for market estimation
  • 1.4 Forecast model
  • 1.5 Primary research and validation
    • 1.5.1 Primary sources
    • 1.5.2 Data mining sources

Chapter 2 Executive Summary

  • 2.1 Industry 360-degree synopsis

Chapter 3 Industry Insights

  • 3.1 Industry ecosystem analysis
  • 3.2 Industry impact forces
    • 3.2.1 Growth drivers
      • 3.2.1.1 Rising incidence of orthopedic disorders
      • 3.2.1.2 Technological advancement in the field orthopedic imaging
      • 3.2.1.3 Growing awareness regarding early disease diagnosis
      • 3.2.1.4 Increasing demand for minimally invasive procedures
    • 3.2.2 Industry pitfalls & challenges
      • 3.2.2.1 Risk of adverse effects from radiation exposure
      • 3.2.2.2 High cost of equipment
  • 3.3 Growth potential analysis
  • 3.4 Technological landscape
  • 3.5 Regulatory landscape
  • 3.6 Porter's analysis
  • 3.7 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

  • 4.1 Introduction
  • 4.2 Company market share analysis
  • 4.3 Competitive positioning matrix
  • 4.4 Strategy outlook matrix

Chapter 5 Market Estimates and Forecast, By Product Type, 2021 - 2032 ($ Mn)

  • 5.1 Key trends
  • 5.2 X-ray system
  • 5.3 CT-scanner
  • 5.4 MRI system
  • 5.5 EOS imaging system
  • 5.6 Ultrasound
  • 5.7 Nuclear imaging system

Chapter 6 Market Estimates and Forecast, By Indication, 2021 - 2032 ($ Mn)

  • 6.1 Key trends
  • 6.2 Trauma cases
  • 6.3 Sport injuries
  • 6.4 Spinal injuries
  • 6.5 Arthritis
  • 6.6 Bone disorders
  • 6.7 Musculoskeletal cancer
  • 6.8 Muscle atrophy
  • 6.9 Other indications

Chapter 7 Market Estimates and Forecast, By End-use, 2021 - 2032 ($ Mn)

  • 7.1 Key trends
  • 7.2 Hospitals
  • 7.3 Diagnostic imaging centers
  • 7.4 Other end-users

Chapter 8 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn)

  • 8.1 Key trends
  • 8.2 North America
    • 8.2.1 U.S.
    • 8.2.2 Canada
  • 8.3 Europe
    • 8.3.1 Germany
    • 8.3.2 UK
    • 8.3.3 France
    • 8.3.4 Spain
    • 8.3.5 Italy
    • 8.3.6 Netherlands
    • 8.3.7 Rest of Europe
  • 8.4 Asia Pacific
    • 8.4.1 Japan
    • 8.4.2 China
    • 8.4.3 India
    • 8.4.4 Australia
    • 8.4.5 South Korea
    • 8.4.6 Rest of Asia Pacific
  • 8.5 Latin America
    • 8.5.1 Brazil
    • 8.5.2 Mexico
    • 8.5.3 Argentina
    • 8.5.4 Rest of Latin America
  • 8.6 Middle East and Africa
    • 8.6.1 Saudi Arabia
    • 8.6.2 South Africa
    • 8.6.3 UAE
    • 8.6.4 Rest of Middle East and Africa

Chapter 9 Company Profiles

  • 9.1 Canon Inc.
  • 9.2 Carestream Health
  • 9.3 EOS imaging
  • 9.4 Esaote SPA
  • 9.5 FUJIFILM Holdings Corporation
  • 9.6 GE HealthCare Technologies Inc.
  • 9.7 Hologic, Inc.
  • 9.8 Koninklijke Philips NV
  • 9.9 Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
  • 9.10 Shimadzu Corporation
  • 9.11 Siemens Healthineers AG